PSA is considered a target for prostate cancer treatment because it is exclusively derived from prostate tissue and participates in prostate cancer signaling pathways such as angiogenesis, invasion, and tumor microenvironment regulation (Moradi et al., 2019). Here, KLK3 is linked to Familial prostate cancer.